Written by the Nuvirox Research Team
Key points
- The clinical definition has four parts: difficulty sleeping, at least three nights a week, for at least three months, with daytime consequences — despite adequate opportunity to sleep.
- There is no hours threshold. You can sleep six hours and not have insomnia; you can sleep seven and have it.
- Under three months it is short-term insomnia, which frequently resolves on its own. That distinction changes what you should do about it.
Short answer: it is defined by frequency, duration and daytime cost — not by how many hours you sleep. Chronic insomnia disorder, as defined in the American Academy of Sleep Medicine's classification and in the DSM-5, requires difficulty initiating sleep, maintaining sleep or waking too early; occurring at least three nights per week; persisting at least three months; producing some daytime impairment; and happening despite adequate opportunity and circumstances for sleep. Nowhere in that list is a number of hours. Which means a lot of people who describe themselves as insomniacs do not meet the definition, and some people who dismiss their own experience do.
What are the actual criteria?
Take them one at a time, because each is doing specific work.
A sleep complaint. Trouble falling asleep, trouble staying asleep, or waking earlier than intended and being unable to return to sleep. Any one qualifies; they often coexist and can swap over time.
Frequency: at least three nights a week. Research using threshold analysis has offered preliminary support for a cut-off around three to four nights per week as the point that best predicts daytime impairment. Two rough nights a week is unpleasant and is not this.
Duration: at least three months. This is the line between short-term and chronic insomnia, and it exists because short-term insomnia frequently resolves without treatment once the trigger passes.
Daytime consequences. Fatigue, low mood or irritability, impaired attention or memory, reduced performance at work or school, or persistent worry about sleep itself. This criterion is the one that excludes a large group of people who sleep unusually little and feel completely fine. If your nights are short and your days are good, the diagnosis does not apply to you.
Adequate opportunity. If you are only allowing yourself five hours in bed because of a second job or a newborn, the problem is sleep restriction imposed by circumstance rather than an inability to sleep. Different problem, different solution.
Why isn't there an hours cut-off?
Because sleep need varies substantially between people, and because self-reported sleep duration is a famously unreliable measurement. Normative data shows total sleep time, sleep efficiency, deep sleep and REM all declining with age while time awake in bed rises — so a fixed hours threshold would label most healthy older adults as disordered.
There is also the phenomenon of sleep state misperception, where the subjective experience of lying awake all night does not match what the recording shows. That is a real and distressing condition in its own right, and we gave it a full treatment in paradoxical insomnia. It is another reason clinicians ask about function rather than counting hours.
Am I just a bad sleeper instead?
Possibly, and it is a legitimate category. Some people are light sleepers by constitution — low arousal threshold, easily disturbed, but functioning fine. Some run late circadian phases and sleep well when allowed to sleep at the hours their body wants, which is a scheduling mismatch rather than an inability to sleep. Some have a genuinely short sleep need. And plenty of people have unremarkable sleep that they have started monitoring too closely, which reliably manufactures anxiety.
The useful test is the daytime one. If you would describe your days as fine, you are not carrying an insomnia disorder regardless of what your nights look like on a chart.
What human studies actually show
The front-line treatment is behavioural, and its effects are specific. A meta-analysis of 20 randomised controlled trials with 1,162 participants found cognitive behavioural therapy for insomnia reduced time to fall asleep by 19.03 minutes (95% CI 14.12 to 23.93) and time awake during the night by 26.00 minutes (95% CI 15.48 to 36.52), with sleep efficiency up 9.91%. Gains appeared sustained at later follow-up and no adverse outcomes were reported.
The honest counterweight, from the same analysis: total sleep time barely moved. The pooled improvement was 7.61 minutes and it was not statistically significant. The most effective treatment we have for chronic insomnia consolidates sleep and reduces the awake time that makes nights feel endless. It does not reliably give you more sleep. If your entire goal is a bigger number, no intervention has strong evidence for delivering it.
Supplements sit in a different weight class. A meta-analysis of 19 placebo-controlled trials in 1,683 people found melatonin shortened sleep latency by about 7 minutes and increased total sleep time by about 8 minutes on average. That is a genuine effect and roughly a third of the latency benefit seen with behavioural therapy.
Pooled post-treatment effects. Bar lengths are scaled for comparison and mix units; the total sleep time result was not statistically significant, which is the point worth noticing.
What this article can't do — and when to see a doctor
Nothing here is a diagnosis. Insomnia is diagnosed by clinical history, and a substantial part of that history is ruling out the things that mimic it. Sleep-disordered breathing, restless legs syndrome, circadian rhythm disorders, thyroid dysfunction, chronic pain, depression and anxiety disorders, and a long list of medications all produce insomnia-shaped complaints and none of them responds to sleep hygiene advice.
Book an appointment rather than self-managing if you snore heavily, have been observed to stop breathing, wake gasping, fall asleep involuntarily during the day, have persistent low mood or hopelessness, are using alcohol to sleep, or are taking any prescription medicine and considering adding a supplement. That last one is not boilerplate: herbal sleep formulas interact with real drugs, and the interaction list is longer than most people expect — we worked through one of the starkest examples in insomnia on endocrine therapy.
If you do meet the criteria, what comes first
Cognitive behavioural therapy for insomnia is the recommended first-line treatment across major guidelines, ahead of medication. Its components — stimulus control, sleep restriction, cognitive work on sleep-related beliefs, and relaxation training — are unglamorous and effective. The catch is access, which is a genuine and widespread problem we wrote about in why CBT-I is so hard to get. Digital and self-help versions exist and have their own evidence base.
Sleep restriction therapy, the component that does the most heavy lifting, is also the most counterintuitive: it deliberately shortens time in bed to rebuild sleep drive. It is worth understanding before you try it, and we walked through it in sleep restriction therapy explained. Regularity of wake time underpins all of it — in a cohort of 60,977 people wearing accelerometers, sleep regularity predicted mortality risk more strongly than duration did.
Frequently asked questions
Can you have insomnia and still sleep seven hours? Yes. If it takes you 90 minutes to fall asleep and you are awake for an hour in the middle of the night, you can still accumulate seven hours across a very long time in bed — and meet every criterion.
Does one bad month count? Not as chronic insomnia. Under three months it is classified as short-term insomnia, which is common, usually tied to an identifiable stressor, and often self-resolving. It is still worth protecting your wake time so it does not become the chronic kind.
Is insomnia a symptom or a disorder? Both, depending on context. Modern classification treats chronic insomnia as a disorder in its own right even when it coexists with depression or pain, because treating it independently usually improves both.
How common is it? Roughly one adult in ten meets criteria for chronic insomnia, while around one in five reports occasional difficulty. The gap between those two figures is mostly the three-month and daytime-impairment criteria doing their job.
From Nuvirox
Why we formulated Sleep+ Restore.
If a clinician has ruled out the medical drivers above and you are looking at general sleep support, this is what we make and what is in it.
- 10 mg melatonin — a circadian timing signal. Published trials mostly use 0.3–5 mg, so 10 mg sits above the studied range for many people; that is a reason to start low and to talk to your prescriber first.
- 905 mg Sleep Formula blend — L-tryptophan, L-theanine, chamomile, lemon balm, passionflower, hops, ashwagandha, Chinese skullcap, goji, GABA, taurine, inositol, St. John's Wort and 5-HTP.
- Vitamin B6, calcium, magnesium — pathway cofactors at nutritional amounts.
- 60-day money-back guarantee.
Please read this part. This formula contains St. John's Wort, which induces the CYP3A4 enzyme system and can lower blood levels of many prescription drugs, and 5-HTP, which raises serotonin-syndrome risk alongside antidepressants and other serotonergic medicines. If you take prescription medication for the condition described in this article, clear this — or any sleep supplement — with your prescriber or pharmacist before you start. That is not a formality. It is the single most important sentence on this page.
The bottom line
Insomnia is a pattern, not a quantity: three nights a week, three months, with your days paying for it, when you had a fair chance to sleep. If that is you, the evidence points firmly at behavioural treatment first and at a clinician who can rule out the conditions that impersonate it. If it is not you — if your nights are imperfect but your days hold up — the most useful thing you can do is stop grading them.
References
- American Academy of Sleep Medicine. International Classification of Sleep Disorders, 3rd edition, text revision (ICSD-3-TR). Darien, IL: AASM; 2023. Diagnostic criteria for chronic insomnia disorder summarised in: Chronic Insomnia. StatPearls. NCBI Bookshelf NBK526136.
- Trauer JM, Qian MY, Doyle JS, Rajaratnam SMW, Cunnington D. Cognitive behavioral therapy for chronic insomnia: a systematic review and meta-analysis. Annals of Internal Medicine. 2015;163(3):191–204. PMID: 26054060. doi:10.7326/M14-2841
- Ohayon MM, Carskadon MA, Guilleminault C, Vitiello MV. Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals: developing normative sleep values across the human lifespan. Sleep. 2004;27(7):1255–1273. PMID: 15586779. doi:10.1093/sleep/27.7.1255
- Ferracioli-Oda E, Qawasmi A, Bloch MH. Meta-analysis: melatonin for the treatment of primary sleep disorders. PLOS ONE. 2013;8(5):e63773. PMID: 23691095. doi:10.1371/journal.pone.0063773
- Windred DP, Burns AC, Lane JM, Saxena R, Rutter MK, Cain SW, Phillips AJK. Sleep regularity is a stronger predictor of mortality risk than sleep duration: a prospective cohort study. Sleep. 2024;47(1):zsad253. PMID: 37738616. doi:10.1093/sleep/zsad253
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.